Updated Mar 23, 2026 by Toho Holdings
TOHO HOLDINGS reported a 3.2% year-over-year decline in consolidated net sales to 595,962 million yen and a 28.6% drop in operating income to 5,458 million yen for the first half of fiscal year 2018.
The dispensing pharmacy business emerged as a growth driver, with net sales increasing 2.2% to 48,204 million yen and operating income surging 590.1% to 1,305 million yen.
The core pharmaceutical wholesaling segment experienced a 3.6% decline in net sales to 570,639 million yen, largely due to a contraction in the hepatitis C curative drug market.
The company launched the KYOSOMIRAI PHARMA generic drug brand, introducing 19 new products across 6 ingredients to capitalize on the industry's shift toward generic alternatives.
Despite the decline in primary financial metrics, the company outperformed its internal budget projections and maintained its original full-year earnings forecast.
Management is prioritizing operational efficiency and high-value service offerings, such as specialized voice-recognition software and examination reservation services, to mitigate market volatility.
TOHO HOLDINGS reported a 3.2% year-over-year decline in consolidated net sales to 595,962 million yen and a 28.6% drop in operating income to 5,458 million yen for the first half of fiscal year 2018.
The dispensing pharmacy business emerged as a growth driver, with net sales increasing 2.2% to 48,204 million yen and operating income surging 590.1% to 1,305 million yen.
The core pharmaceutical wholesaling segment experienced a 3.6% decline in net sales to 570,639 million yen, largely due to a contraction in the hepatitis C curative drug market.
The company launched the KYOSOMIRAI PHARMA generic drug brand, introducing 19 new products across 6 ingredients to capitalize on the industry's shift toward generic alternatives.
Despite the decline in primary financial metrics, the company outperformed its internal budget projections and maintained its original full-year earnings forecast.
Management is prioritizing operational efficiency and high-value service offerings, such as specialized voice-recognition software and examination reservation services, to mitigate market volatility.